Trial Profile
Treatment With Botulinum Toxin Type A (BOTOX) in Chinese Patients With Moderate to Severe Frown Lines.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Apr 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Sponsors Allergan
- 28 Apr 2015 New trial record